0001127602-14-021372.txt : 20140626
0001127602-14-021372.hdr.sgml : 20140626
20140619164759
ACCESSION NUMBER: 0001127602-14-021372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140617
FILED AS OF DATE: 20140619
DATE AS OF CHANGE: 20140619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
BUSINESS PHONE: 2054444600
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 14930834
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-06-17
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001230708
STAAB THOMAS R II
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior Vice President and CFO
Common Stock
2014-06-17
4
M
0
3125
4.73
A
147426
D
Common Stock
2014-06-17
4
S
0
3125
12.00
D
144301
D
Emp. Stock Option (Right to Buy)
4.73
2014-06-17
4
M
0
3125
0
D
2013-03-01
2022-03-01
Common Stock
3125
21750
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 26, 2014.
/s/ Alane P. Barnes, by power of attorney
2014-06-19